BDMD · Baird Medical Investment Holdings Ltd
$1.03
-0.04 (-3.74%)
At close · Jul 29
Market Cap
$42.21M
Shares
40.98M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$22.54M
-39.2%
FY2025
Net Income
-$27.28M
-319%
FY2025
Gross Margin
83.79%
-4.4pp
FY2025
Operating Margin
-113.73%
-155.1pp
FY2025
Diluted EPS
-$0.98
-271.9%
FY2025
Operating Cash Flow
-$1.34M
+78.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| $22.54M | $37.04M | $31.46M | $35.09M | |
| $3.65M | $4.38M | $4.23M | $7.05M | |
| $18.88M | $32.65M | $27.23M | $28.04M | |
| 83.79% | 88.16% | 86.56% | 79.9% | |
| $20.13M | $6.17M | $4.27M | $3.86M | |
| $10.26M | $4.06M | $2.55M | $3.59M | |
| $14.12M | $7.1M | $8.55M | $6.96M | |
| $8391 | $8384 | $22.64K | $53.55K | |
| $1.1M | $1.14M | $1.01M | $916.12K | |
| $44.51M | $17.34M | $15.37M | $14.41M | |
| -$25.63M | $15.32M | $11.86M | $13.63M | |
| -113.73% | 41.35% | 37.71% | 38.85% | |
| -$24.53M | $16.45M | $12.88M | $14.55M | |
| $737.37K | $576.36K | $284.27K | $299.27K | |
| — | $393 | $1562 | $8553 | |
| -$100.2K | -$651.66K | -$10.21K | -$194.58K | |
| -$26.37M | $14.09M | $12.36M | $14.52M | |
| $1.17M | $1.49M | $1.7M | $1.75M | |
| -$27.28M | $12.45M | $10.55M | $12.77M | |
| -121.04% | 33.62% | 33.52% | 36.41% | |
| -$263.12K | $144.73K | $112.21K | $206.22K | |
| -$27.28M | $12.45M | $10.55M | $12.57M | |
| -$25.51M | $11.32M | $9.82M | $11.06M | |
| USD/shares | -$0.98 | $0.57 | $0.51 | $0.49 |
| USD/shares | -$0.98 | $0.57 | $0.51 | $0.49 |
| shares | 27.79M | 21.83M | 20.59M | 25.56M |
| shares | 27.79M | 21.83M | 20.59M | 25.56M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.24×
EV/EBIT
—
Peer median 18.00×
P/E (TTM)
—
Peer median 8.32×
Peer medians compare against the 74 similar-size Medical Devices companies (of 146 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| China | $13,495,375 | $36,184,886 | $31,457,908 |
| Hong Kong SAR China | $7,988,415 | — | — |
| United States | $938,745 | $852,222 | — |
| Malaysia | $106,002 | — | — |
| Nepal | $8,479 | — | — |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Microwave Ablation Needles | $17,214,751 | $33,826,455 | $26,278,169 | $30,551,145 |
| Microwave Ablation Therapeutic Apparatus | $5,322,265 | $3,200,822 | $4,662,214 | $732,089 |
| Other Medical Devices | — | $9,831 | $517,525 | $3,807,940 |